Cytokines and pulmonary fibrosis

Gauldie, J; Jordana, M; Cox, G
September 1993
Thorax;Sep1993, Vol. 48 Issue 9, p931
Academic Journal
No abstract available.


Related Articles

  • Role of the myofibroblast in pulmonary fibrosis. PHAN, SEM H. // Kidney International Supplement;May1996, Issue 54, pS-46 

    The authors discuss the origination of myofibroblasts with alpha-smooth muscle actin phenotype that are found in pulmonary fibrosis. They mention that the myofibroblasts could be influenced by cytokines such as transforming growth factors-beta. Myofibroblasts may be the primary cause of...

  • Tumor necrosis factor alpha gene expression in human monocytic THP-1 cells exposed to beryllium. Galbraith, Gillian M.P.; Pandey, Janardan P. // Archives of Environmental Health;Jan/Feb96, Vol. 51 Issue 1, p29 

    Focuses on chronic beryllium disease, which results from occupational exposure to particulate beryllium. Development of lung granulomas and progressive pulmonary fibrosis; Cytokine production by human monocytic cells exposed to beryllium in vitro; Effects of inhaled beryllium.

  • Modern Concepts on the Role of Inflammation in Pulmonary Fibrosis. Homer, Robert J.; Elias, Jack A.; Lee, Chun Gun; Herzog, Erica // Archives of Pathology & Laboratory Medicine;Jun2011, Vol. 135 Issue 6, p780 

    Context.-Idiopathic pulmonary fibrosis is a uniformly lethal disease with limited biomarkers and no proven therapeutic intervention short of lung transplantation. Pulmonary fibrosis at one time was thought to be a result of inflammation in the lung. Although some forms of pulmonary fibrosis may...

  • Mechanisms of Colchicine Effect in the Treatment of Asbestosis and Idiopathic Pulmonary Fibrosis. Addrizzo-Harris, D.J.; Harkin, T.J.; Tchou-Wong, K.M.; McGuinness, G.; Goldring, R.; Cheng, D.; Rom, D.W.N. // Lung;2002, Vol. 180 Issue 2, p61 

    The objective of this study was to evaluate the mechanisms of colchicine action in pulmonary fibrosis. The study included 10 patients with pulmonary fibrosis (idiopathic pulmonary fibrosis 5, asbestosis 4, and scleroderma 1) who had been admitted to Bellevue Hospital Center, a tertiary care...

  • Molecular Mechanisms of and Possible Treatment Strategies for Idiopathic Pulmonary Fibrosis. Gharaee-Kermani, M.; Phan, S. H. // Current Pharmaceutical Design;Nov2005, Vol. 11 Issue 30, p3943 

    Pulmonary fibrosis is characterized by lung inflammation and abnormal tissue repair, resulting in the replacement of normal functional tissue with an abnormal accumulation of fibroblasts and deposition of collagen in the lung. This process involves cellular interactions via a complex...

  • Rho/Rock信号通路与肺纤维化相关性的研究进展. 漆秀洁; 李静; 谭利平; 许峰; 方芳 // Journal of Shanghai Jiaotong University (Medical Science);Oct2016, Vol. 36 Issue 10, p1533 

    Rho/Rock signaling pathway is a key signaling pathway regulating cell proliferation and tissue differentiation, as well as a signal transduction pathway moderating stem cell self-renewal process. Under the stimulation of a various inflammatory cytokines, Rho/Rock pathway is involved in...

  • The role of CXC chemokines in pulmonary fibrosis. Strieter, Robert M.; Gomperts, Brigitte N.; Keane, Michael P. // Journal of Clinical Investigation;Mar2007, Vol. 117 Issue 3, p549 

    The CXC chemokine family is a pleiotropic family of cytokines that are involved in promoting the trafficking of various leukocytes, in regulating angiogenesis and vascular remodeling, and in promoting the mobilization and trafficking of mesenchymal progenitor cells such as fibrocytes. These...

  • SCIENTIFIC ASPECTS OF LUNG FIBROSIS.  // Thorax;Dec2001 Supp, Vol. 56, piii5 

    This article presents various studies related to scientific aspects of lung fibrosis. According to a study. Interferon-gamma (IFN-y), a Thi cytokine, may attenuate the decline in lung function in patients with idiopathic pulmonary fibrosis. These effects may be partly mediated by decreased...

  • Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. Daniels, Craig E.; Wilkes, Mark C.; Edens, Maryanne; Kottom, Ted J.; Murphy, Stephen J.; Limper, Andrew H.; Leof, Edward B. // Journal of Clinical Investigation;Nov2004, Vol. 114 Issue 9, p1308 

    Idiopathic pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Prior efforts to treat idiopathic pulmonary fibrosis that focused on anti-inflammatory therapy have not proven to be effective. Recent insight suggests that the pathogenesis is mediated...

  • Interleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis. Minrui Liang; Jiucun Wang; Haiyan Chu; Xiaoxia Zhu; Hang He; Qiong Liu; Jianhua Qiu; Xiaodong Zhou; Ming Guan; Yu Xue; Xiangjun Chen; Hejian Zou // Mediators of Inflammation;2013, Vol. 2013, p1 

    Pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Recent insight has suggested that early injury/inflammation of alveolar epithelial cells could lead to dysregulation of tissue repair driven by multiple cytokines. Although dysregulation of...


Read the Article


Sign out of this library

Other Topics